Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€52.51
22.12.21
€55.00
22.12.22
-7.45%
23.12.22

Could be worthwhile Investment >10% per year
melinda 
22.12.21 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€203.15
17.12.21
-
17.12.22
31.43%
18.12.22

Letue35 
17.12.21 0%
buy
Medtronic plc

Start price
Target price
Perf. (%)
€99.12
14.12.21
-
14.12.22
-25.68%
15.12.22

MBU 
14.12.21 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€82.42
28.11.22
€100.00
28.11.23
1.15%
10.12.22

gerihouse_ctm 
28.11.22 80%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€48.36
06.12.21
€60.00
06.12.22
-0.12%
06.12.22

Could be worthwhile Investment >10% per year
Ritter_in_weiss 
06.12.21 50%
buy
Laboratory Corp. Of America (labcorp)

Start price
Target price
Perf. (%)
€259.70
02.09.21
€280.00
14.02.23
-11.99%
04.12.22

RudolfL 
02.09.21 60%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€316.75
29.10.22
-
29.11.22
-3.65%
30.11.22

piano 
29.10.22 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€79.55
28.10.22
-
28.11.22
3.51%
29.11.22

piano 
28.10.22 50%
buy
Illumina Inc.

Start price
Target price
Perf. (%)
€333.50
27.11.21
-
27.11.22
-37.03%
28.11.22

melinda 
27.11.21 40%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€140.70
27.11.21
€160.00
27.11.22
21.35%
28.11.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
MoneyMoney 
27.11.21 0%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€216.45
20.10.22
€230.00
20.11.22
16.61%
21.11.22

melinda 
20.10.22 50%
sell
Johnson & Johnson

Start price
Target price
Perf. (%)
€176.04
01.11.22
-
01.11.23
-6.85%
12.11.22

fenjal 
01.11.22 50%
sell
Davita Inc.

Start price
Target price
Perf. (%)
€71.57
29.10.22
€35.00
29.10.23
-2.56%
12.11.22

nvestor 
29.10.22 50%
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€10.85
16.08.22
-
16.08.23
2.45%
10.11.22

fenjal 
16.08.22 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€533.60
09.11.21
€600.00
09.11.22
38.91%
10.11.22

Could be worthwhile Investment >10% per year
melinda 
09.11.21 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€338.70
07.10.22
€350.00
07.10.23
7.12%
29.10.22

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
07.10.22 80%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.87
15.05.22
€68.00
15.05.23
32.12%
28.10.22

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
RudolfL 
15.05.22 50%
buy
Davita Inc.

Start price
Target price
Perf. (%)
€73.02
28.10.22
-
0.45%
28.10.22

Risky Investment
Wolf_of_WS 
28.10.22 50%
buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€70.68
28.10.22
-
28.10.23
2.39%
28.10.22

Risky Investment
Wolf_of_WS 
28.10.22 50%
buy
Align Technology

Start price
Target price
Perf. (%)
€269.30
29.05.22
€380.00
29.05.23
-31.58%
27.10.22

RudolfL 
29.05.22 60%
sell
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€70.76
26.10.21
€65.00
26.10.22
38.64%
27.10.22

Could be worthwhile Investment >10% per year
melinda 
26.10.21 50%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€169.38
18.07.22
-
18.07.23
-10.01%
26.10.22

CrazyEights 
18.07.22 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€533.60
18.08.22
€550.00
18.08.23
2.72%
25.10.22

Traumtanz 
18.08.22 60%
buy
Humana Inc.

Start price
Target price
Perf. (%)
€374.20
17.10.21
€400.00
17.10.22
36.00%
18.10.22

Achim_le_Lion 
17.10.21 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€65.72
13.10.22
-
-
13.10.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Snowman 
13.10.22 50%